Abstract
Background: Hepatitis C infection can often be detected by antibodies to the hepatitis C virus. HCV infection frequently goes untreated since it is asymptomatic for decades before symptoms appear as a result of severe liver damage. This study will investigate the prevalence of HCV in the Western region, specifically the Sekondi-Takoradi metropolis. The research sought to improve the knowledge gap by providing data on the prevalence rates of HCV. Methods: 980 samples collected from January to April 2022 were subjected to a retrospective analysis. The HCV serologic test was performed using the one-step immune-chromatographic test kit. Age-related data and the results of all serologic tests for HCV were recorded and evaluated during analysis. Results: A total number of 980 samples were analyzed in this study. Out of which 91.3% (n=895) were seronegative and the remaining 8.7% (n=85) were seropositive. Seropositivity was mainly found significantly among the 35-44, Conclusion: This study recorded a high prevalence rate of HCV seropositivity. To the best of our knowledge, this is the first study in the Western region to have considered HCV prevalence. The findings emphasize the necessity for quick public health measures to lower infection rates. These must target screening of high-risk groups, education campaigns about HCV transmission patterns, and the provision of treatment for those who are infected.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: American Journal of Infectious Diseases and Microbiology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.